2023 Vizient PSO Topical Safety Webinar Series: Early identification and response to clinical deterioration

September 13, 2023

The presenters will use clinical deterioration as an exemplar for how artificial intelligence and machine learning is used to identify and intervene on high risk patients. They will present 2 models and 3 use cases that include how rapid response teams and night medicine attending providers apply AI to prevent clinical deterioration. There are also a number of considerations and governance aspects when using AI and the presenters will discuss those concerns and how the applications are used to augment the human based workflows. The presentation will also share information on how large language models like GPT can play a role in identifying clinical deterioration.

Target Audience

  • Nurses
  • Pharmacists
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

1.    Discuss the prevalence of the maternal health crisis in the United States. 
2.    Define AI/machine learning.
3.    Discuss how these concepts can be applied to predict and prevent clinical deterioration.
4.    Discuss considerations and governance aspects for implementing AI and machine learning in healthcare.
5.    Describe the importance of incorporating human engagement in AI/machine learning
6.    Describe the role of large language models in identifying clinical deterioration.

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.81 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE – Attendance
Course opens: 
08/11/2023
Course expires: 
10/28/2023
Event starts: 
09/13/2023 - 1:00pm CDT
Event ends: 
09/13/2023 - 2:00pm CDT
Add to calendar: 
Live Activity
United States

Relevant Financial Relationships  

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

 

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company. 

 

Eric Oermann, speaker for this educational activity has the following to disclose:

 

Company Name

Nature of Financial Relationship

Google Inc.

Consultant

Sofinnova Partners

Consultant

Mirati Therapeutics

Employee (Spouse)

Merck & Co.

Employee (Spouse)

Artisight Inc.

Equity

 

 

All relevant financial relationships listed for these individual(s) have been mitigated. 

 

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

 

Faculty & Planners

 

Planning Committee 

Ellen Flynn, RN, MBA, JD, CPPS (Course Director)    

Principal, Vizient Inc.

 

Tammy Williams, MSN, RN, CPPS

Program Director, Vizient Inc.

 

Kathryn Merkeley, MHSA, RN, PMP, CPPS

Program Director, Vizient Inc.

 

Christina Driskill, MPH, RN, CPHQ

Program Director, Vizient Inc.

 

Jay Prystowski, MD, MBA

Principal, Vizient Inc.

 

James Lichauer, Pharm.D., BCPS, FASHP

PI Program Director, Vizient Inc.

 

Faculty

Yin Aphinanaphongs, MD/PhD

Director of Operational Data Science and Machine Learning

NYU Langone Health

 

Eric Oermann, MD

Assistant Professor of Neurosurgery, Radiology, and Data Science

NYU Langone Health

 

Paul Testa, MD, JD, MPH

Chief Medical Information Officer

NYU Langone Health

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
 
 
 
 
 
Credit Designation Statement(s)
 
Nurses
This activity is designated for 1.00 contact hours.
Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.50 contact hours.
 
Pharmacists
Vizient, Inc. designates this activity for a maximum of for 1.00 contact hour(s) for all pharmacists.
Universal Activity Number: JA0006103-0000-23-133-L05-P
 
Physicians
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professionals
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation indicating the maximum credits available.
 
Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE – Attendance
Please login or register to take this course.

Select the Obtain Credit button to access the course evaluation and to claim CE Credit.